Studies shed light on pain perception, placebo effect pathways, and how human stem cells can be used to model pain. Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master's degree in ...
A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.
A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain.
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...